Home›People›Antoine Barouky
AB

Antoine Barouky

Director at Andros Medicines.

Director
Updated Nov 10, 2026·Latest SEC filing Jul 1, 2026·Suggest an edit

About Antoine Barouky

Antoine Barouky is a director at Andros Medicines.

Experience

This experience comes from Antoine Barouky's profile and from SEC filings. For roles taken from filings, the years are when the filings name Antoine Barouky in the role, so the role may have started earlier or lasted longer.

Valerio Therapeutics Current
Non-Executive Director / Board Member
2024 – Present
Invus Current
Venture Partner
2023 – Present
AB Global Strategy Current
Founder & CEO
2023 – Present
Andros Medicines Inc.
Director
2026 · Boston, MA
Stanford University
Joint Research Committee, Stanford Innovative Medicines Accelerator
2023 – 2026
Alnylam Pharmaceuticals
VP General Manager & International Business Development
2016 – 2023
Shire
Rare Diseases Head (Fabry, Gaucher, MPS/Hunter & HAE products & services)
2015 – 2016
Cubist Pharmaceuticals
Vice President, General Manager France & BENELUX
2014 – 2015
Allergan
SVP Southern Europe & General Manager France
2012 – 2014
Stallergenes
Senior Vice President, Business and Corporate Development (2010 – 2012)
SVP Global Marketing, Medical Affairs, Market Access, Communication, Business Planning (2000 – 2010)
2000 – 2012
Laboratoire BIOMNIS
International Product Manager
1997 – 2000

Key Colleagues at Startups

The people Antoine Barouky works with at each company, as listed on that company's latest Form D.

Andros Medicines Inc. · Form D, Jul 1, 2026
JM
John Maraganore
President and CEO, director
KB

Sources

  1. SECAndros Medicines Inc. Form D, filed Jul 1, 2026